Qyresearchreports include new market research report "Global Personalized Medicines Market Size, Status and Forecast 2018-2025" to its huge collection of research reports.
New York, NY -- (SBWIRE) -- 01/26/2019 -- The report on the global market for Personalized Medicines uses several benchmarks to predict the potential for growth within the market. The key dynamics pertaining to the global market for Personalized Medicines have been knit together to help the readers in reaching pragmatic conclusions with regards to market growth. Furthermore, the researchers of this report have followed an unbiased approach to understand the apparent and obscure aspects of the global market for Personalized Medicines. The report considers the dominant forces operating in related markets in order to paint a holistic picture of the global market for Personalized Medicines.
Fill the form to gain deeper insights on this market @ https://www.qyresearchreports.com/sample/sample.php?rep_id=1884626&type=S
This report focuses on the global Personalized Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicines development in United States, Europe and China.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
In 2017, the global Personalized Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 9.5% during 2018-2025.
The key players covered in this study
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
...
Market segment by Type, the product can be split into
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
To Browse a Complete Report with TOC Visit @ https://www.qyresearchreports.com/report/global-personalized-medicines-market-size-status-and-forecast-2018-2025.htm
Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze and study the global Personalized Medicines capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Personalized Medicines manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Personalized Medicines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Personalized Medicines Manufacturers
Personalized Medicines Distributors/Traders/Wholesalers
Personalized Medicines Subcomponent Manufacturers
Industry Association
Downstream Vendors
About QYResearchReports.com
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Follow Us on LinkedIn: https://www.linkedin.com/company/qyresearchreports-com
Email: sales@qyresearchreports.com